{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:05:34Z","timestamp":1793829934441,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00292-020-00801-z","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T21:06:36Z","timestamp":1592514396000},"page":"478-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hepatozellul\u00e4res Karzinom","Hepatocellular carcinoma"],"prefix":"10.1007","volume":"41","author":[{"given":"Thomas","family":"Longerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"801_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.humpath.2007.06.004","volume":"39","author":"HM Abdul-Al","year":"2008","unstructured":"Abdul-Al\u00a0HM, Makhlouf\u00a0HR, Wang\u00a0G et al (2008) Glypican\u20113 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma. Hum Pathol 39:209\u2013212","journal-title":"Hum Pathol"},{"key":"801_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1478-3231.2008.01849.x","volume":"29","author":"P Bioulac-Sage","year":"2009","unstructured":"Bioulac-Sage\u00a0P, Laumonier\u00a0H, Rullier\u00a0A et al (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a\u00a0novel easy diagnostic tool in surgical pathology. Liver Int 29:459\u2013465","journal-title":"Liver Int"},{"key":"801_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray\u00a0F, Ferlay\u00a0J, Soerjomataram\u00a0I et\u00a0al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 68:394\u2013424","journal-title":"CA A Cancer J Clin"},{"key":"801_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","volume":"67","author":"J Calderaro","year":"2017","unstructured":"Calderaro\u00a0J, Couchy\u00a0G, Imbeaud\u00a0S et\u00a0al (2017) Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J\u00a0Hepatol 67:727\u2013738","journal-title":"J Hepatol"},{"key":"801_CR5","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/hep.28710","volume":"64","author":"J Calderaro","year":"2016","unstructured":"Calderaro\u00a0J, Rousseau\u00a0B, Amaddeo\u00a0G et\u00a0al (2016) Programmed death ligand 1 expression in hepatocellular carcinoma: relationship With clinical and pathological features. Hepatology 64:2038\u20132046","journal-title":"Hepatology"},{"key":"801_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network (2017) Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169:1327\u20131341.e23","journal-title":"Cell"},{"key":"801_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/PAS.0000000000000376","volume":"39","author":"AW Chan","year":"2015","unstructured":"Chan\u00a0AW, Tong\u00a0JH, Pan\u00a0Y et al (2015) Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome. Am J Surg Pathol 39:304\u2013312","journal-title":"Am J Surg Pathol"},{"key":"801_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/jhep.2003.50022","volume":"37","author":"M Chuma","year":"2003","unstructured":"Chuma\u00a0M, Sakamoto\u00a0M, Yamazaki\u00a0K et\u00a0al (2003) Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a\u00a0molecular marker of early hepatocellular carcinoma. Hepatology 37:198\u2013207","journal-title":"Hepatology"},{"key":"801_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S","volume":"46","author":"JR Craig","year":"1980","unstructured":"Craig\u00a0JR, Peters\u00a0RL, Edmondson\u00a0HA et al (1980) Fibrolamellar carcinoma of the liver: a\u00a0tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46:372\u2013379","journal-title":"Cancer"},{"key":"801_CR10","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jhep.2008.11.014","volume":"50","author":"L Di Tommaso","year":"2009","unstructured":"Di Tommaso\u00a0L, Destro\u00a0A, Seok\u00a0JY et\u00a0al (2009) The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J\u00a0Hepatol 50:746\u2013754","journal-title":"J Hepatol"},{"key":"801_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/hep.21531","volume":"45","author":"L Di Tommaso","year":"2007","unstructured":"Di Tommaso\u00a0L, Franchi\u00a0G, Park\u00a0YN et\u00a0al (2007) Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 45:725\u2013734","journal-title":"Hepatology"},{"key":"801_CR12","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1053\/j.gastro.2017.09.008","volume":"153","author":"LH Engelholm","year":"2017","unstructured":"Engelholm\u00a0LH, Riaz\u00a0A, Serra\u00a0D et al (2017) CRISPR\/Cas9 engineering of adult mouse liver demonstrates that the Dnajb1-Prkaca gene fusion is sufficient to induce tumors resembling Fibrolamellar Hepatocellular carcinoma. Gastroenterology 153:1662\u20131673 e10","journal-title":"Gastroenterology"},{"key":"801_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00292-018-0565-0","volume":"40","author":"HP Fischer","year":"2019","unstructured":"Fischer\u00a0HP, Goltz\u00a0D (2019) Hepatocellular carcinomas and their mimics. Pathologe 40:101\u2013118","journal-title":"Pathologe"},{"key":"801_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/modpathol.2017.103","volume":"31","author":"RP Graham","year":"2018","unstructured":"Graham\u00a0RP, Yeh\u00a0MM, Lam-Himlin\u00a0D et al (2018) Molecular testing for the clinical diagnosis of fibrolamellar carcinoma. Mod Pathol 31:141\u2013149","journal-title":"Mod Pathol"},{"key":"801_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jhep.2019.12.006","volume":"72","author":"TZ Hirsch","year":"2019","unstructured":"Hirsch TZ, Negulescu A, Gupta B et al (2019) BAP1 mutations define a\u00a0homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA. J\u00a0Hepatol 72:924\u2013936","journal-title":"J\u00a0Hepatol"},{"key":"801_CR16","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1249484","volume":"343","author":"JN Honeyman","year":"2014","unstructured":"Honeyman\u00a0JN, Simon\u00a0EP, Robine\u00a0N et al (2014) Detection of a\u00a0recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 343:1010\u20131014","journal-title":"Science"},{"key":"801_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1440-1746.1994.tb01569.x","volume":"9","author":"F Kondo","year":"1994","unstructured":"Kondo\u00a0F, Kondo\u00a0Y, Nagato\u00a0Y et\u00a0al (1994) Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views. J\u00a0Gastroenterol Hepatol 9:604\u2013612","journal-title":"J Gastroenterol Hepatol"},{"key":"801_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/hep.1840090516","volume":"9","author":"F Kondo","year":"1989","unstructured":"Kondo\u00a0F, Wada\u00a0K, Nagato\u00a0Y et al (1989) Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 9:751\u2013755","journal-title":"Hepatology"},{"key":"801_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0168-8278(97)80321-2","volume":"27","author":"B Le Bail","year":"1997","unstructured":"Le Bail\u00a0B, Bernard\u00a0PH, Carles\u00a0J et\u00a0al (1997) Prevalence of liver cell dysplasia and association with HCC in a\u00a0series of 100 cirrhotic liver explants. J\u00a0Hepatol 27:835\u2013842","journal-title":"J Hepatol"},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/01.pas.0000213323.97294.9a","volume":"30","author":"L Libbrecht","year":"2006","unstructured":"Libbrecht\u00a0L, Severi\u00a0T, Cassiman\u00a0D et al (2006) Glypican\u20113 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 30:1405\u20131411","journal-title":"Am J Surg Pathol"},{"key":"801_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/1471-2407-14-425","volume":"14","author":"CC Liu","year":"2014","unstructured":"Liu\u00a0CC, Jan\u00a0YJ, Ko\u00a0BS et al (2014) 14-3-3sigma induces heat shock protein 70 expression in hepatocellular carcinoma. Bmc Cancer 14:425","journal-title":"Bmc Cancer"},{"key":"801_CR22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/gutjnl-2018-317632","volume":"68","author":"T Longerich","year":"2019","unstructured":"Longerich\u00a0T, Endris\u00a0V, Neumann\u00a0O et al (2019) RSPO2 gene rearrangement: a\u00a0powerful driver of beta-catenin activation in liver tumours. Gut 68:1287\u20131296","journal-title":"Gut"},{"key":"801_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/hep.22709","volume":"49","author":"International Consensus Group for Hepatocellular Neoplasia","year":"2009","unstructured":"International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658\u2013664","journal-title":"Hepatology"},{"key":"801_CR24","first-page":"215","volume-title":"WHO classification of tumours\u2014digestive system tumours","author":"V Paradis","year":"2019","unstructured":"Paradis\u00a0V, Fukayama\u00a0M, Park\u00a0YN et\u00a0al (2019) Tumours of the liver and intrahepatic bile ducts. In: Lokuhetty\u00a0D, White\u00a0VA, Watanabe\u00a0R, Cree\u00a0IA (Hrsg) WHO classification of tumours\u2014digestive system tumours. International Agency for Research on Cancer (IARC), Lyon, S\u00a0215\u2013264"},{"key":"801_CR25","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/cncr.22460","volume":"109","author":"YN Park","year":"2007","unstructured":"Park\u00a0YN, Kojiro\u00a0M, Di Tommaso\u00a0L et\u00a0al (2007) Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 109:915\u2013923","journal-title":"Cancer"},{"key":"801_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/00000478-199806000-00002","volume":"22","author":"YN Park","year":"1998","unstructured":"Park\u00a0YN, Yang\u00a0CP, Fernandez\u00a0GJ et\u00a0al (1998) Neoangiogenesis and sinusoidal \u201ccapillarization\u201d in dysplastic nodules of the liver. Am J Surg Pathol 22:656\u2013662","journal-title":"Am J Surg Pathol"},{"key":"801_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbapap.2014.10.024","volume":"1854","author":"H Reis","year":"2015","unstructured":"Reis\u00a0H, Putter\u00a0C, Megger\u00a0DA et al (2015) A structured proteomic approach identifies 14-3-3Sigma as a\u00a0novel and reliable protein biomarker in panel based differential diagnostics of liver tumors. Biochim Biophys Acta 1854:641\u2013650","journal-title":"Biochim Biophys Acta"},{"key":"801_CR28","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/0140-6736(90)92768-D","volume":"336","author":"T Takayama","year":"1990","unstructured":"Takayama\u00a0T, Makuuchi\u00a0M, Hirohashi\u00a0S et\u00a0al (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336:1150\u20131153","journal-title":"Lancet"},{"key":"801_CR29","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5","volume":"51","author":"S Watanabe","year":"1983","unstructured":"Watanabe\u00a0S, Okita\u00a0K, Harada\u00a0T et\u00a0al (1983) Morphologic studies of the liver cell dysplasia. Cancer 51:2197\u20132205","journal-title":"Cancer"},{"key":"801_CR30","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/modpathol.2013.68","volume":"26","author":"LD Wood","year":"2013","unstructured":"Wood\u00a0LD, Heaphy\u00a0CM, Daniel\u00a0HD et\u00a0al (2013) Chromophobe hepatocellular carcinoma with abrupt anaplasia: a\u00a0proposal for a\u00a0new subtype of hepatocellular carcinoma with unique morphological and molecular features. Mod Pathol 26:1586\u20131593","journal-title":"Mod Pathol"},{"key":"801_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s005350050387","volume":"34","author":"S Yamamoto","year":"1999","unstructured":"Yamamoto\u00a0S, Takashima\u00a0S, Ogawa\u00a0H et al (1999) Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma. J\u00a0Gastroenterol 34:640\u2013644","journal-title":"J Gastroenterol"},{"key":"801_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hep.29762","volume":"68","author":"M Ziol","year":"2018","unstructured":"Ziol\u00a0M, Pote\u00a0N, Amaddeo\u00a0G et al (2018) Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance. Hepatology 68:103\u2013112","journal-title":"Hepatology"},{"key":"801_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/sj.onc.1209824","volume":"26","author":"J Zucman-Rossi","year":"2007","unstructured":"Zucman-Rossi\u00a0J, Benhamouche\u00a0S, Godard\u00a0C et al (2007) Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene 26:774\u2013780","journal-title":"Oncogene"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00801-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-020-00801-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00801-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T23:21:36Z","timestamp":1623972096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-020-00801-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1007\/s00292-020-00801-z","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"18 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Longerich gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}